Chunhua Qiushi Words "Shuangxi"
Release time:
2021-03-22
Time flies, time flies, and in a twinkling of an eye 20 years of spring and autumn are solid. Looking back on the career journey of Jianfeng Pharmacy 20 years, the increase of stores, the growth of sales, the growth of professional team ... are the results of everyone's concerted efforts. And our Shuangxi store has also completed the upgrade from ordinary pharmacies to designated pharmacies for medical insurance to designated pharmacies for chronic diseases. At the same time, we have also won many honors: star stores in Zhejiang chain industry, demonstration units for honest management in Jinhua city, advanced collectives in peak medicine, etc. Along the way, every footprint permeates the sweat and hardship of every colleague, and every step of growth is accompanied by the efforts and persistence of every colleague.
2020 is an extraordinary year. The new coronavirus pneumonia epidemic is sweeping, and the situation of prevention and control of the epidemic in various places is very serious. In this war without gunpowder smoke, front-line medical personnel, police officers, volunteers, and caring people from all sides are fighting on the front line. As the drugstore staff at the grassroots level, we also play an extremely important role. After the outbreak of the epidemic, the people's demand for masks, alcohol, disinfectants, heat-clearing and detoxification drugs has skyrocketed. Large pharmacies have adopted multi-channel, squatting, door-to-door and other methods to do everything possible to grab goods and look for sources of goods on the spot. However, when the logistics of our shop assistants is almost paralyzed, all the employees and their families drive private cars to the battle, regardless of the year, day and night, either on the way to the warehouse or on the way to deliver goods, thus satisfying the people's demand for medical supplies to the maximum extent. In the high-risk situation at that time, the store staff still stuck to the front line and still adhered to the purpose of "customer satisfaction " . While doing a good job in self-protection, warmly welcome customers who come to buy drugs, record their needs and opinions in time, patiently answer inquiries about diseases, and strengthen the publicity of epidemic prevention and control knowledge and precautions. For customers who are in the controlled area and are not convenient to purchase drugs at the store, we provide timely on-site service. As the drug supervision department's key epidemic prevention and control supervision "sentinel " pharmacy, we operate in strict accordance with the epidemic prevention and control requirements every day, enter the store personnel registration, temperature measurement, bright health code, guide customers to wear masks, store regular disinfection, epidemic monitoring varieties for real-name registration, timely reporting, to build a barrier to fight against the new coronary pneumonia epidemic.
Affected by the outbreak, we have been wearing masks for almost the whole year. The mask obscures half of our faces without closing "The window to the mind " . We pass on the beauty and hope of life through our eyes. We do the most common things every day, but when the world stops, we still insist on doing this thing, then it has a different meaning.
We are an important window of Jianfeng Group, adhering to its spirit of serving the society and the public. 20 years, whether in difficult times or ordinary every day, under the guidance of this spirit, under the continuous efforts of all people in Shuangxi, our predecessors and us have worked hard for the spring and autumn of Shuangxi and contributed to the continuous growth of Shuangxi in the future. We are also proud of such an excellent collective.
(Shuangxi Pharmacy Huang Xiaolin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page